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Introduction
Nematode glutamate-gated chloride channels (GluCl) have attracted considerable attention as the site of action of the avermectin/milbemycin class of anthelmintics (Arena et al., 1992; Wolstenholme and Rogers, 2005) . The mode of action of these drugs is very interesting: they act as almost irreversible, long-acting agonists both at recombinant and native GluCl (Cully et al., 1994; Brownlee et al., 1997; Holden-Dye and Walker, 2006) . In addition, at concentrations lower than those that cause direct activation of the channels, they potentiate the response to sub-maximal concentrations of L-glutamate (Cully et al., 1994; Forrester et al., 2003; Vassilatis et al., 1997) .
The GluCl are members of the cys-loop ligand-gated ion channel family and there is a small family of genes encoding GluCl subunits in both free-living and parasitic nematodes (Williamson et al., 2007; Yates et al., 2003) . One member of this gene family that is widely conserved is avr-14, which has been found in Caenorhabditis elegans, Haemonchus contortus, Ascaris suum, Cooperia oncophora, the cyathostomins (parasites of horses), and the filarial parasites infecting humans and companion animals (Dent et al., 2000; Jagannathan et al., 1999; Laughton et al., 1997; Njue et al., 2004; Tandon et al., 2006; Yates and Wolstenholme, 2004) . The gene is alternatively spliced in most of these species to yield two subunits, GluClα3A and GluClα3B, which share a common N-terminal ligand-binding domain, but differ in the C-terminal channel-forming domains. Previous studies on these subunits have indicated that the GluClα3B subunit can form channels that bind radiolabelled ivermectin (22,23-dihydroavermectin B1 a ) (Campbell et al., 1983) with very high affinity (Cheeseman et al., 2001) , and are activated by L-glutamate-and ivermectin This article has not been copyedited and formatted. The final version may differ from this version.
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The expression pattern of this gene has been studied using reporter gene constructs, which would not distinguish between the two splice variants, in C. elegans, (Dent et al., 2000) and specific antibodies against the conserved N-terminal and variable Cterminal regions in H. contortus (Jagannathan et al., 1999; Portillo et al., 2003) . In both species, gene expression was detected in extrapharyngeal neurons in the head, sensory neurons and ventral cord motor neurons, and in H. contortus expression of the GluClα3A subunit was also detected in amphid neurons with the GluClα3B subunit found in three putative pharyngeal neurons. Mutations in avr-14 have been associated with avermectin resistance in C. elegans and C. oncophora (Dent et al., 2000; Njue et al., 2004) . In C. oncophora, three amino-acid differences, E114G, V235A and L256F, were found between the GluClα3 subunits from avermectin-susceptible andresistant worms. The resultant recombinant channels from the resistant isolate were 3.2 fold less sensitive to L-glutamate and 2.6 fold less sensitive to ivermectin than those from the susceptible isolate and this difference was wholly due to the L256F polymorphism alone (Njue et al., 2004) . Avermectin resistance has become a major problem in agricultural parasites , notably in H. contortus, and may be emerging in human parasites (Osei-Atweneboana et al., 2007) . Since changes in GluClα3B have been implicated in resistance, we studied the ability of glutamate and ivermectin to activate the channels it forms, as well as the effect of candidate resistance mutations, identified both in GluCl and in other ligand-gated chloride channels, on its interactions with the drug. This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods
Materials
All common chemicals and biochemicals were from Sigma, Poole, Dorset, UK. The mMessage mMachine T7 RNA transcription kit was from Ambion Inc. (Huntingdon, UK). Mature female Xenopus laevis were supplied by Blades Biologicals (Kent, UK).
Restriction enzymes were from Promega (Southampton, UK). Fipronil was a gift from Aventis CropScience (Frankfurt, Germany).
Site-directed mutagenesis and cRNA synthesis.
Site directed Mutagenesis was carried out using Stratagene QuickChange mutagenesis kit (Stratagene, La Jolla, USA). Plasmid DNA (10μg) was linearised using the restriction enzyme Xba-1, extracted with phenol:chloroform and precipitated with 
Expression in Xenopus oocytes and two-electrode voltage clamp recordings
Mature female Xenopus laevis were killed by terminal anaesthesia in 0.2% (w/v) benzocaine solution (10% w/v in ethanol, diluted 1:50 with water). Ovarian lobes were dissected out under sterile conditions and placed in OR2 calcium-free buffer (82mM NaCl, 1mM MgCl 2 , 2mM KCl, 5 mM HEPES, pH7.5). The lobes were then teased into small clumps of oocytes and washed several times with OR2. Oocyte This article has not been copyedited and formatted. The final version may differ from this version. Oocytes were placed in a perspex chamber and perfused with Ringer solution (100mM NaCl, 2mM KCl, 1.8mM CaCl 2 , 1mM MgCl 2 , 5mM HEPES, pH 7.5). Two glass microelectrodes (0.5 -5 mΩ resistance) were attached to HS-2A pre-amplifiers (Axon Instruments, Union City, CA, USA) and inserted through the oocyte membrane. The resting membrane potential was displayed on a GeneClamp 500B voltage clamp amplifier (Axon Instruments). Typically, an oocyte resting membrane potential difference was seen to be -30 to -50 mV. Current was injected through one microelectrode to increase this value to -80mV where it was held (clamped) throughout the perfusion experiments.
L-Glutamic acid, ibotenic acid, aspartic acid, glycine, GABA, histamine and 5-hydroxytryptamine were all dissolved in Ringer solution at high concentration (100mM-1M), adjusted to pH7.5 and diluted appropriately before perfusion through the oocyte chamber for 5-10 seconds. A washing period of 5 minutes was allowed This article has not been copyedited and formatted. The final version may differ from this version. 
Expression in COS-7 cells and radioligand binding assays
A full-length H. contortus cDNA encoding GluClα3B was subcloned into pcDNA3.1.
One day before transfection, tissue-culture dished were seeded with COS-7 cells at a density so that they were 90-95% confluent at the time of transfection. Transfection of the cDNA was accomplished using Lipofectamine 2000, and cells incubated at 37°C in an incubator with 5 % CO 2 for 18-48 hours prior to harvesting membrane protein.
The culture medium was removed by aspiration from the plate and the cells washed three times with room temperature 50mM HEPES with 0.01% (w/v) sodium azide (pH 7.4). Cells were harvested with a cell scraper in 5 ml of the 50 mM HEPES with 0.01% (w/v) sodium azide and placed in a 15 ml universal centrifuge tube. The cells were further disrupted by sonication in 3x 10 second bursts on medium power.
The medium was made up to 10 ml with more 50mM HEPES with 0.01% sodium azide and added to a 10 ml ultracentrifuge tube. The cells were centrifuged at 75,000g
for 30 minutes at 4°C. The supernatant was discarded and the cells resuspended in 1 ml 50 mM HEPES with 0.01% (w/v) sodium azide and 0.2 mM PMSF. 
Molecular modelling
A BLAST search (Altschul et al., 1997) through NCBI was used to identify structures homologous to the GluCl by searching the structural database of protein sequences in the protein data bank (PDB) (Berman et al., 2000) . A parallel comparison was carried out using the MODELLER program. The crystal structure of the acetylcholine binding protein from Lymnea stagnalis (PDB code: 1I9BA) was selected as a template for the homology modeling for the GluClα3B subunit. This protein was the top alignment from the MODELLER search and the best match over 50 amino-acids long from the BLAST search. The amino acid sequences of GluClα3B and 1I9B were aligned using the align2d command in MODELLER, which aligns multiple sequences using a pairwise progressive alignment algorithm: the two polypeptides were 21% This article has not been copyedited and formatted. The final version may differ from this version. satisfaction of spatial restraints on the structure of the amino acid sequence. All structures and models were visualised using the protein explorer 2.80 (file:///C:/Program%20Files/Protein_Explorer_2.80/protexpl/frntdoor.htm). The stereochemical, volume and surface properties of the models were evaluated using modeller and procheck (Laskowski et al., 1993) which were accessed via www.bichem.ucl.ac.uk/~roman/procheck/procheck.html. This article has not been copyedited and formatted. The final version may differ from this version. 
Results
The cDNAs encoding the H. contortus GluClα3A, α 3B (Jagannathan et al., 1999 ) and Delany et al., 1998) subunits, and the C. elegans GluClα3B (Laughton et al., 1994) subunit, were transcribed into cRNA in vitro and microinjected into Xenopus oocytes.
After 2-6 days incubation oocytes were voltage-clamped at -80mV and tested for responses to 1mM L-glutamate. Responses were detected only from oocytes injected with GluClα3B cRNA, either alone or in combination with the other cRNAs ( Figure   1 ). No responses were detected from either uninjected or water-injected control oocytes: both controls were carried out on 3-4 oocytes from each experimental batch indicating that it is a partial agonist at this receptor.
Ivermectin was also able to activate the HcGluClα3B channels, although, as has been previously shown for other nematode GluCl (Cully et al., 1994; Dent et al., 1997; Forrester et al., 2004; Horoszok et al., 2001; Njue et al., 2004; Pemberton et al., 2001; Vassilatis et al., 1997) , the activation was slow and irreversible ( Figure 1C ).
These properties made it difficult to determine an accurate EC 50 for this activation, and this problem was compounded by our observation that it was not the size of the response, it terms of the peak current, that was dose-dependent, but the rate at which the channels opened and that current was obtained ( Figure 1D ). The lowest concentration of ivermectin which produced robust responses was 0.1nM, and application of concentrations ≥ 1nM reliably induced channel opening. With the limitations described, we estimated an EC 50 for ivermectin of 0.1 ± 1.0 nM at this receptor, with a very high apparent Hill number (> 6) ( Figure 1E ).
Previously, picrotoxinin and fipronil have been reported to antagonise the glutamate responses at some, but not all, nematode GluCl. We found that picrotoxinin would This article has not been copyedited and formatted. The final version may differ from this version. (Figure 2A ). Fipronil (10μM) blocked the glutamate-induced channels by 74±7 %, though in this case the block was not reversed, even by extensive (30 mins) washing ( Figure 2B ). Picrotoxinin (1mM) also reversibly reduced a maximal ivermectin response by up to 56±7% ( Figure 2C ) and fipronil (100μM) also partially reduced a similar response by 35% ( Figure 2D ). In this case, the fipronil block was reversible and terminated by washing.
In order to test whether changes in the GluClα3B subunit could contribute to ivermectin resistance, we created mutant forms of the GluClα3B cDNA that contained the three potential ivermectin resistance-associated mutations identified by Njue et al (2004) , plus an additional mutation, T300S, previously observed in ivermectinresistant H. contortus in our laboratory (Jagannathan, 1998) (Figure 3 ). These were then expressed in the Xenopus oocyte system and the responses to glutamate measured. Two of the mutants, E114G and V235A, produced channels practically identical to wild-type ( Figure 4 and Table 1 ), and T300S failed to produce any channels at all. When T300S was co-expressed with wild-type channels at a ratio of 1:1 (based on the amount of injected cRNA), the channels produced were identical to wild-type (data not shown). Attempts to determine whether this was due to a failure of this subunit to express correctly were unsuccessful. The final mutation, L256F, caused a shift in the dose-response curve to L-glutamate to the right, increasing the EC 50 to 92.2 ± 3.5 µM and also resulted in a significant loss of co-operativity in the receptor, with the Hill number decreasing to 1.09 ± 0.16.
This article has not been copyedited and formatted. The final version may differ from this version. Since obtaining good quantitative data using ivermectin in the oocyte system had proved problematic, we turned to radio-ligand binding assays to study the effects of the mutations on the interaction between ivermectin and the GluClα3B receptor (Cheeseman et al., 2001 ). The mutant subunits were expressed in COS-7 cells and their ability to bind [ 3 H]-ivermectin measured ( Figure 5 ). In these experiments, the wild-type subunit bound the drug with a K d of 0.35 ± 0.1 nM. In this system, the T300S mutant was expressed successfully and was able to bind the drug, with a K d of 0.76 ± 0.25 nM. The E114G and V235A mutants again gave results very similar to wild-type, while the L256F mutant showed a significantly increased K d of 2.26 ± 0.78 nM. We therefore introduced some additional mutations at this position, finding the substitution of any aromatic amino-acid for L256 caused a significant increase in the K d for ivermectin, none of which were significantly different from L256F ( Table 2 ), but that the more conservative substitution of a valine had a reduced effect, producing a receptor with a K d of 0.74 ± 0.24 nM.
In an attempt to gain some insight into the possible mechanisms via which mutations at amino-acid residue 256 might cause the observed changes in receptor properties, we attempted to model the three-dimensional structure of the extracellular domain of the GluClα3B subunit, using the known structure of the soluble acetylcholine-binding protein from Lymnaea stagnalis (Brejc et al., 2001 ) as a template. This protein has been widely used as a template for modelling the structures of members of the cysloop ligand-gated ion channel superfamily, though its sequence similarity to the GluCl (53%) is rather lower than to the nicotinic receptors. The model of the wild-type extracellular domain is shown in Figure 6 . We looked at the effects of the mutations at position 256 on this model. The wild-type amino-acid, leucine, is adjacent to a This article has not been copyedited and formatted. The final version may differ from this version. relatively large number of other amino acid residues, and in the pentameric structure is found in the centre of the outside face of the extracellular channel (Fig 6) . The two residues that are most closely in association with the L256 are V235, which is interesting as the V235A mutation was found in association with L256F, and L193. In the wild-type channel the leucine appears to be neither attracted nor repulsed by any of its neighbours, as they all possess relatively unreactive sidechains. The modelling of the L256F substitution results in an obvious interaction with the neighbouring polar amino acid N191 in which an attraction seems to be occurring. This phenomenon is also seen with the L256V and L245Y mutations, though the L256W has no apparent effect on the N191 residue. All of the mutations at position 256 were predicted to cause a change in the orientation of amino-acid K254. Position 235 is found at the bottom of the β -sandwich in a highly conserved area of β 10 the ninth β -strand of the sandwich. On the pentameric structure it is found on the outside facing edge and interacts primarily with residues on the final β 11 strand. The most important of these residues is L256. However, the V235A change is not predicted to have any major effect on the surrounding amino-acids.
This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
Ivermectin and its related compounds are the most important anthelmintics available today and as such, we need to better understand their mode of action, and how resistance, already an established problem in veterinary medicine, might develop. H.
contortus is an important parasite in which ivermectin resistance has already become widespread; given the possibility that this resistance might be due to changes in the GluCl that are the drug target (McCavera et al., 2007; Njue et al., 2004) , we have examined the effects of candidate resistance-associated mutations in this receptor. We have confirmed that the products of the nematode avr-14 gene can be activated by low concentrations of ivermectin; indeed, the H. contortus GluClα3B subunit forms channels activated by much lower concentrations of both the natural ligand, glutamate, and the anthelmintic than does the corresponding subunit from either C.
elegans or another parasite, Dirofilaria immitis (Yates and Wolstenholme, 2004) . The reasons for this increased sensitivity, also seen with the GluClα3B subunit of Cooperia oncophora (Njue et al., 2004) , are not known, nor is it biological significance understood. Unlike C. elegans or C. oncophora (Cully, 1994; Njue et al., 2004) , we could find no evidence of channels formed by, or incorporating, the GluClβ subunit of H. contortus. This suggests that the GluCl of different nematode species are rather different, supporting observations that ivermectin has varying effects on nematodes (Behnke et al., 1993; Holden-Dye and Walker, 2006; Sheriff et al., 2002) .
One contributory factor to the difference between the C. elegans and H. contortus GluClα3B channels might be that the amino-acid residue at position 256 in C. elegans is phenylalanine rather than leucine and the L256F change has been associated with resistance in C. oncophora. Though we have confirmed that introducing an aromatic This article has not been copyedited and formatted. The final version may differ from this version. amino-acid at this position does alter the response of the channel to both glutamate and ivermectin, the effect is not large enough to explain the difference in EC 50 for glutamate between the homologous receptors from H. contortus and C. elegans, which is two orders of magnitude. Otherwise, the pharmacology of the H. contortus
GluClα3B channel is similar to that reported for other GluCl, with ibotenate acting as a partial agonist and picrotoxin acting as a channel blocker. The antagonist affects of fipronil confirm that the fiproles do have activity against nematode ligand-gated chloride channels (Horoszok et al., 2001 ).
The effects of introducing an aromatic amino-acid at position 256 were interesting.
Though the apparent efficacy of glutamate and the affinity of ivermectin were both reduced, it was noteworthy that this was accompanied by a change in the shape of the dose-response curve, and a reduction in the Hill number, suggestive of a loss of cooperativity rather than a change in the actual binding site of either drug or agonist.
Since the expressed channels are homomers and hence possess five possible binding sites, it may be that the region of the subunit around position 256, which is at the Cterminal end of the N-terminal extracellular domain ( Figure 6 ) is involved in communication between subunits, rather than directly in ligand binding. Whatever the mechanism, our data confirm those of Njue et al. (2004) and that this is a candidate polymorphism associated with ivermectin resistance. We are currently assessing whether or not it is present in resistant isolates of H. contortus. So far, we have had no success. The T300S polymorphism, originally found in an ivermectin-resistant isolate of H. contortus (Jagannathan, 1998) (Jagannathan et al., 1999) it is a possibility that the substitution results in a blocked channel that does not allow chloride ions to pass through. However, confirmation that this mutant expresses in the oocyte plasma membrane is necessary to confirm this possibility: it was expressed well in the COS-7 cells since the radiolabelled ivermectin binding was similar (in terms of B max as well as K d ) to that of wild-type. However, ligand binding does not require the channel to be expressed in the plasma membrane.
The molecular modelling results suggest that the GluCl have the same basic fold as other members of the cys-loop ligand-gated ion channels, notably the nicotinic acetylcholine receptors. Though the similarity between the GluCl subunit we modelled and the acetylcholine binding protein (53%) was not great enough to permit detailed predictions of the structure of the agonist binding site, it seems likely that this site, as in the nicotinic receptors, is located at the interface between adjacent subunits.
The changes in co-operativity that we saw when this residue was mutated may indicate that this region of the protein is involved in mediating allosteric effects between adjacent binding sites rather than directly in binding ligands.
